Paul Talmo - Feb 23, 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Strategic Officer
Signature
/s/ Megan Smeykal, Attorney-in-fact
Stock symbol
TELA
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 04:09 PM
Previous filing
Jan 7, 2022
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +12.2K +40.04% $0.00 42.7K Feb 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +20.9K $0.00 20.9K Feb 23, 2022 Common Stock 20.9K $11.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.